CAGT houses two Good Manufacturing
Practices (GMP) facilities for the
preparation of cell and gene therapy
products for use in Phase I/II clinical trials.

In addition there is a Quality Control
Laboratory, that performs testing on
products and the manufacturing
environment, and a Flow Cytometry Facility
for analysis of therapeutic cells.

The staff have considerable experience in
preparing a wide range of cell and gene
therapy products in one of the largest
academic GMP facilities in North America.

The Cell Processing Facility is one of three
national somatic cell therapy processing
laboratories contracted by the National
Heart Lung and Blood Institute under its
Production Assistance for Cell Therapy program 

 

The Vector Production Facility is a National
Gene Vector Laboratory for the
manufacture of adenoviral vectors

The CAGT GMP Facilities are accredited by:

  

CAGT Home | BCM Home | Privacy Notices